Atlas Trials

Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults

Clinical trial NCT00830804 · COMPLETED

Trial details

NCT number
NCT00830804
Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1 Infections
Start date
2009-04-01
Primary completion
2010-02-01
Enrollment
113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.